CDC 2023 Immunization Updates for 5 Vaccine-Preventable Illnesses
The US Centers for Disease Control and Prevention (CDC) issued updated immunization schedules in February 2023 for both adults and children.
The following Guideline Topline highlights updates in the immunization schedule for: pneumococcal disease; measles, mumps, and rubella; hepatitis B; polio; and monkeypox.
In an earlier Guideline Topline we highlighted the changes affecting the 3 primary respiratory viruses that will soon begin circulating for the 2023-24 "flu" season, influenza, COVID-19, and respiratory syncytial virus.
Where relevant, we note recommendations from recent meetings of the CDC's Advisory Committee on Immunization Practices (ACIP).
Pediatric Pneumococcal Vaccination: Use of either PCV15 or PCV20 is recommended for all children aged 2–23 mos according to currently recommended PCV dosing and schedules.
Pediatric PCV Vaccination Catch-up. For children aged 6–18 yrs with any risk condition who have not received any dose of PCV13, PCV15, or PCV20, a single dose of PCV15 or PCV20 is recommended.
Pneumococcal Vaccine Choice for Adults aged ≥65 Years. Choice depends on what has previously been received; see example above.
Measles, Mumps, Rubella Option. June 2022, ACIP recommended Priorix as second option to prevent MMR, considering it noninferior to M-M-R II and the 2 vaccines fully interchangeable.
Hepatitis B New Listing. PreHevbio® added to CDC Immunization Schedule table of vaccine abbreviations and trade names.
Polio Protection. Adults who are known or suspected to be unvaccinated or incompletely vaccinated against polio should complete a primary vaccination series with inactivated polio vaccine.
